Updating results

96 results for dyspepsia Sort: Relevance | Date

Dyspepsia and gastro-oesophageal reflux disease

In this pathway infants are defined as under 1 year, children 1 to under 12 years, young people 12 to under 18 years and adults 18 years and older. Infants, children and young peopleGastro-oesophageal reflux is a normal physiological process that

NICE Pathway Published September 2014 Last updated December 2016

The clinical and cost effectiveness of proton pump inhibitors for the treatment of dyspepsia (TA7)

This guidance has been updated and replaced by gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

Technology appraisal guidance Published July 2000 Withdrawn

Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

...conducted to exclude a diagnosis of functional dyspepsia in people with uninvestigated dyspepsia that does not respond to PPIs or H2 receptor...if applicable) People with uninvestigated dyspepsia that fails to respond to PPIs or H2RAs, despite...

Research recommendation Published June 2015

Dyspepsia: Management of dyspepsia in adults in primary care (CG17)

This guidance has been updated and replaced by gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

Clinical guideline Published August 2004 Withdrawn

The way to medicines optimisation is through the stomach - tackling high prescribing levels using the NICE Dyspepsia guideline to review proton pump inhibitor (PPI) prescribing.

...Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management...Full title of NICE guidance: CG184 - Dyspepsia and gastro‑oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of gastro & oesophageal...

Shared learning Published January 2013 Last updated April 2015

Suspected cancer recognition and referral

This pathway covers the recognition and selection for referral or investigation in primary care of people of all ages, including children (aged from birth to 15 years) and young people (aged 16 to 24), who may have cancer. Although the terms 'men'

NICE Pathway Published June 2015 Last updated September 2016

Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

...treating severe erosive reflux disease. Source guidance details Comes from guidance Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Number CG184 Date issued September 2014 Other details Is this a recommendation for...

Research recommendation Published June 2015

Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

...GORD being non-responsive to PPIs. Source guidance details Comes from guidance Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Number CG184 Date issued September 2014 Other details Is this a recommendation for...

Research recommendation Published June 2015

Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

...should focus on improving quality of life. Source guidance details Comes from guidance Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Number CG184 Date issued September 2014 Other details Is this a recommendation for...

Research recommendation Published June 2015

Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

...to exclude Barrett's oesophagus). Source guidance details Comes from guidance Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Number CG184 Date issued September 2014 Other details Is this a recommendation for...

Research recommendation Published June 2015

Head and neck cancer (QS146)

Evidence-based statements to deliver quality improvements in assessing, diagnosing and managing head and neck cancer in young people and adults

Quality standard Published March 2017

Irritable bowel syndrome in adults: diagnosis and management (CG61)

Evidence-based recommendations on diagnosing and managing irritable bowel syndrome (IBS) in adults

Clinical guideline Published February 2008 Last updated February 2015

Coeliac disease: recognition, assessment and management (NG20)

Evidence-based recommendations on the recognition, assessment and management of coeliac disease in children, young people and adults.

NICE guideline Published September 2015

Coeliac disease

Coeliac disease is an autoimmune condition associated with chronic inflammation of the small intestine, which can lead to malabsorption of nutrients. Dietary proteins, known as glutens, which are present in wheat, barley and rye activate an abnormal

NICE Pathway Published October 2012 Last updated October 2016

Cerebral palsy in under 25s: assessment and management (NG62)

Evidence-based recommendations on diagnosing, assessing and managing cerebral palsy in children and young people under 25

NICE guideline Published January 2017

Non-Hodgkin’s lymphoma: diagnosis and management (NG52)

Evidence-based recommendations on diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over

NICE guideline Published July 2016

Heavy menstrual bleeding

This pathway covers heavy menstrual bleeding.Heavy menstrual bleeding is defined as excessive menstrual blood loss which interferes with a woman's physical, social, emotional and/or material quality of life. It can occur alone or in combination with

NICE Pathway Published February 2012 Last updated August 2016

Myocardial infarction: secondary prevention

This pathway covers the secondary prevention of MI in primary and secondary care.MI is one of the most dramatic presentations of coronary artery disease. It is usually caused by blockage of a coronary artery producing tissue death and consequently

NICE Pathway Published November 2013 Last updated December 2016

Idiopathic pulmonary fibrosis

This pathway covers the diagnosis and management of suspected idiopathic pulmonary fibrosis in adults.Idiopathic pulmonary fibrosis is a chronic, progressive fibrotic interstitial lung disease of unknown origin. It is a difficult disease to diagnose

NICE Pathway Published June 2013 Last updated January 2016

Gastrointestinal conditions

This pathway includes recommendations on gastrointestinal conditions, including conditions of the oesophagus, stomach, small intestine, gallbladder, pancreas, large intestine, rectum and anus.

NICE Pathway Published November 2013 Last updated January 2017

Smokeless tobacco: South Asian communities (PH39)

Evidence-based recommendations on the cessation of smokeless tobacco (including misri, qimam, naswar and gutkha) for people of South Asian origin

Public health guideline Published September 2012

Heavy menstrual bleeding: assessment and management (CG44)

Evidence-based recommendations on heavy menstrual bleeding (HMB)

Clinical guideline Published January 2007 Last updated August 2016

Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (TA160)

Evidence-based recommendations on alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic

Technology appraisal guidance Published October 2008 Last updated January 2011

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (TA275)

Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (AF)

Technology appraisal guidance Published February 2013

Barrett's oesophagus: ablative therapy (CG106)

Evidence-based recommendations on care and treatment of adults having ablative therapy to treat Barrett’s oesophagus with high-grade dysplasia…

Clinical guideline Published August 2010

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (CG68)

Evidence-based recommendations on the diagnosis and initial management of stroke and transient ischaemic attack (TIA or ‘mini-stroke’) in over 16s

Clinical guideline Published July 2008 Last updated March 2017